Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]
{{output}}
This podcast episode reviews recent advances in the treatment of IDH1-mutant acute myeloid leukemia (AML), focusing on the mechanisms, efficacy, and safety profiles of approved IDH1 inhibitors. The purpose is to present expert insights and clinical data from k... ...
